Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22

Trial Status

Recruiting1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT06834035Phase 1/2Recruiting
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Dystrophic Epidermolysis BullosaEpidermolysis BullosaEpidermolysis Bullosa Acquisita+1 more
PrincipalinvestigatorStart date: 2025-08-04
NCT07011589Phase 1/2Not Yet Recruiting
Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)
Dystrophic Epidermolysis BullosaEpidermolysis Bullosa (EB)Epidermolysis Bullosa Acquisita+1 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sabine Hazan, MD

ProgenaBiome

Related
41 trials

Shared therapeutic areas:

Epidermolysis BullosaEpidermolysis Bullosa Dystrophica
Similarity Score15%

Sarah Abdelwahab, MD

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score15%

Jean Tang, MD

Stanford University

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score15%

Jean Tang, MD, PhD

Stanford University

Related
4 trials

Shared therapeutic areas:

Epidermolysis BullosaEpidermolysis Bullosa Dystrophica

Worked with same sponsors:

Epidermolysis Bullosa Research Partnership
Similarity Score15%

Alfred Lane, MD

Stanford University

Related
3 trials

Shared therapeutic areas:

Epidermolysis BullosaEpidermolysis Bullosa Dystrophica
Similarity Score15%

Angela Iheanacho, MS

Abeona Therapeutics, Inc

Related
2 trials

Shared therapeutic areas:

Epidermolysis BullosaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score15%

David Chien, MD

Senior Vice President of Clinical Development

Related
3 trials

Shared therapeutic areas:

Epidermolysis Bullosa DystrophicaRecessive Dystrophic Epidermolysis Bullosa
Similarity Score15%

Alfred T Lane

Stanford University

Related
2 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score8%

Herbert B Slade, MD

Healthpoint

Related
18 trials

Shared therapeutic areas:

Epidermolysis Bullosa Dystrophica
Similarity Score8%

Amy S Paller, MD

Northwestern University

Related
4 trials

Shared therapeutic areas:

Epidermolysis Bullosa
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT06834035Phase 1/2PrincipalInvestigator

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Dystrophic Epidermolysis BullosaEpidermolysis BullosaEpidermolysis Bullosa Acquisita+1 more
Recruiting
NCT07011589Phase 1/2PrincipalInvestigator

Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

Dystrophic Epidermolysis BullosaEpidermolysis Bullosa (EB)Epidermolysis Bullosa Acquisita+1 more
Not Yet Recruiting

All 2 trials loaded